Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from MustGrow Biologics ( (TSE:MGRO) ) is now available.
MustGrow Biologics has completed a two-year, roughly 100-acre field trial program in the Canadian Prairies showing that its mustard-based biocontrol product TerraMG can significantly suppress Clubroot, a destructive soil-borne disease that threatens Canada’s $14 billion canola sector, while improving yields and root health under varying disease pressures. In a wetter 2024 season with high disease prevalence, TerraMG-treated plots recorded up to a 95% reduction in Clubroot spores and yield gains of up to 7 bushels per acre, equating to about $91 per acre in added farmer value, and in the drier 2025 season still delivered modest yield improvements, positioning TerraMG as a promising sustainable solution in a market currently lacking effective registered products for Clubroot suppression and potentially strengthening MustGrow’s role in integrated disease management for canola producers.
The most recent analyst rating on (TSE:MGRO) stock is a Hold with a C$0.71 price target. To see the full list of analyst forecasts on MustGrow Biologics stock, see the TSE:MGRO Stock Forecast page.
Spark’s Take on TSE:MGRO Stock
According to Spark, TipRanks’ AI Analyst, TSE:MGRO is a Neutral.
The score is held down primarily by weak financial performance—deep losses and significant negative free cash flow—despite modest leverage. Technicals are a relative bright spot with improving short- to mid-term momentum, but valuation remains pressured by negative earnings and no indicated dividend support.
To see Spark’s full report on TSE:MGRO stock, click here.
More about MustGrow Biologics
MustGrow Biologics Corp. is a Saskatchewan-based agricultural biotechnology company developing mustard-derived organic biocontrol products targeting soil-borne diseases and pests in high-value crops. Through its Canadian marketing and distribution arm NexusBioAg, the company focuses on sustainable crop protection solutions intended to improve soil conditions, crop yields and root health, with a particular emphasis on major field crops such as canola in the Canadian Prairies.
Average Trading Volume: 70,171
Technical Sentiment Signal: Sell
Current Market Cap: C$43.55M
Find detailed analytics on MGRO stock on TipRanks’ Stock Analysis page.